Phlow Corp, based in U.S.A, is a pharmaceutical company.
One of their notable products is SUCCINYLCHOLINE CHLORIDE, USP, with a corresponding US DMF Number 37095.
Remarkably, this DMF maintains an Active status since its submission on December 15, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 02, 2023, and payment made on February 16, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II